Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $119.02 | 0.78% | 6.10% | 29.98% | 104.43% | 247.61% | 69.57% | 278.80% | 484.29% | 2,052.26% | $122.21 | $28.66 | 2.61% | 315.28% | 1.01 | 847,000 | 10.43% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $242.61 | 6.12% | 8.33% | -11.02% | -17.56% | -28.51% | -47.06% | 28.55% | 23.16% | 233.35% | $495.55 | $197.81 | 51.04% | 22.65% | 0.86 | 1,833,000 | 14.56% |
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $80.80 | 1.65% | 3.39% | 29.11% | 51.48% | 71.30% | 143.74% | 369.49% | 592.97% | N/A | $82.94 | $32.89 | 2.58% | 145.67% | 0.80 | 820,000 | 123.43% |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $26.46 | -0.30% | 0.68% | -3.89% | 35.69% | -5.33% | 67.79% | 263.71% | 34.93% | N/A | $31.77 | $15.10 | 16.71% | 75.23% | 1.21 | 923,000 | -53.00% |
| ADMA | ADMA BIOLOGICS INC | $10.05 | 5.35% | 2.76% | 14.86% | 16.45% | -38.42% | -42.37% | 148.76% | 717.07% | 79.14% | $20.46 | $7.21 | 50.87% | 39.39% | 1.18 | 2,689,000 | 102.64% |
| HALO | HALOZYME THERAPEUTICS INC | $107.62 | 2.60% | 5.73% | 39.60% | 56.58% | 49.39% | 53.79% | 152.51% | 179.75% | 978.36% | $107.96 | $61.23 | 0.31% | 75.78% | 0.76 | 2,539,000 | 30.07% |
| VCEL | VERICEL CORP | $43.57 | -1.56% | -2.59% | -5.03% | 26.33% | 14.15% | 20.46% | 34.56% | -12.44% | 1,836.44% | $49.32 | $28.95 | 11.66% | 50.50% | 1.45 | 592,000 | 11.49% |
| KRYS | KRYSTAL BIOTECH INC | $343.34 | 3.16% | 3.15% | 1.21% | 17.06% | 30.71% | 138.50% | 173.43% | 560.14% | N/A | $382.54 | $136.73 | 10.25% | 151.11% | 1.29 | 151,000 | 3.42% |
| RPRX | ROYALTY PHARMA PLC | $61.73 | 3.42% | 4.24% | 7.74% | 17.78% | 36.84% | 71.47% | 108.27% | 58.77% | N/A | $61.80 | $34.08 | 0.11% | 81.13% | 0.45 | 3,244,000 | 60.04% |
| TGTX | TG THERAPEUTICS INC | $51.69 | 2.85% | 4.42% | -4.21% | 31.09% | 75.46% | 85.14% | 398.46% | 137.33% | 754.38% | $59.30 | $26.76 | 12.83% | 93.16% | 1.83 | 1,199,000 | 4.44% |
| ZVRA | ZEVRA THERAPEUTICS INC | $12.13 | 4.84% | 6.03% | 0.83% | 18.92% | 36.45% | 34.70% | 139.72% | 36.29% | -85.42% | $15.04 | $7.16 | 19.32% | 69.41% | 0.89 | 1,088,000 | 23.22% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $69.33 | 3.49% | -1.30% | 17.29% | 39.19% | 9.32% | 20.97% | -22.86% | -7.28% | -24.63% | $70.98 | $49.26 | 2.32% | 40.75% | 0.70 | 1,923,000 | 7.43% |
| NAGE | NIAGEN BIOSCIENCE INC | $3.17 | 3.59% | 3.59% | -5.93% | -13.62% | -35.83% | -67.08% | 104.52% | -59.72% | -15.92% | $10.52 | $2.87 | 69.87% | 10.45% | 1.51 | 803,000 | 55.02% |
| LGND | LIGAND PHARMACEUTICALS INC | $290.71 | 1.08% | -0.87% | -1.12% | 39.91% | 56.03% | 88.69% | 339.01% | 184.09% | 173.02% | $326.63 | $154.91 | 11.00% | 87.66% | 1.13 | 231,000 | 1.76% |
| VRTX | VERTEX PHARMACEUTICALS INC | $552.06 | 4.52% | 5.01% | 14.89% | 27.11% | 17.64% | 41.28% | 57.40% | 183.05% | 463.27% | $553.69 | $374.17 | 0.29% | 47.54% | 0.57 | 1,437,000 | -4.01% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $252.16 | -0.36% | 1.29% | 3.57% | 6.19% | 48.69% | 111.54% | 81.95% | 91.74% | 85.11% | $265.03 | $118.19 | 4.86% | 113.35% | 0.69 | 476,000 | 4.62% |
| SPRO | SPERO THERAPEUTICS INC | $1.23 | 2.50% | 3.36% | -14.58% | -52.51% | -48.75% | -33.15% | -3.91% | -90.56% | N/A | $3.08 | $1.08 | 60.06% | 13.89% | 0.78 | 479,000 | 0.63% |
| TECH | BIO-TECHNE CORP | $72.48 | 0.36% | 0.35% | 1.17% | 59.40% | 24.43% | 32.09% | -7.88% | -39.08% | 170.57% | $72.62 | $43.20 | 0.19% | 67.78% | 1.14 | 2,452,000 | -3.20% |
| MDXG | MIMEDX GROUP INC | $4.45 | 2.53% | 3.97% | 2.77% | 22.25% | -14.42% | -38.11% | -39.78% | -63.61% | -39.04% | $7.97 | $3.03 | 44.17% | 47.11% | 1.24 | 1,151,000 | -5.27% |
| EXEL | EXELIXIS INC | $54.39 | 2.39% | 7.96% | -2.05% | 11.75% | 23.17% | 44.96% | 154.52% | 205.73% | 394.45% | $57.57 | $33.76 | 5.52% | 61.13% | 0.60 | 2,239,000 | 73.57% |
| UTHR | UNITED THERAPEUTICS CORP | $529.14 | 2.10% | 3.40% | -0.04% | -6.64% | 10.12% | 68.94% | 128.93% | 163.19% | 316.91% | $609.35 | $302.19 | 13.16% | 75.10% | 0.41 | 414,000 | 14.68% |
| REGN | REGENERON PHARMACEUTICALS INC | $840.84 | 3.78% | 5.37% | 25.10% | 33.40% | 7.47% | 47.06% | -0.42% | 28.25% | 107.97% | $844.90 | $541.00 | 0.48% | 55.42% | 0.59 | 732,000 | 26.64% |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $39.93 | 2.83% | 0.40% | 19.19% | 31.18% | 16.11% | 9.70% | 23.51% | 26.44% | N/A | $40.87 | $25.52 | 2.30% | 56.47% | 0.81 | 734,000 | 61.67% |
| INCY | INCYTE CORP | $128.47 | 4.05% | 6.38% | 11.09% | 34.38% | 26.29% | 50.33% | 98.01% | 72.42% | 68.80% | $132.58 | $81.09 | 3.10% | 58.43% | 0.53 | 1,498,000 | 25.78% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.